高级检索
当前位置: 首页 > 详情页

K137R Mutation on Adeno-Associated Viral Capsids Had Minimal Effect on Enhancing Gene Delivery In Vivo

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

单位: [1]Univ N Carolina, Div Mol Pharmaceut, Eshelman Sch Pharm, Chapel Hill, NC 27599 USA [2]Univ N Carolina, Gene Therapy Ctr, Dept Pediat, Chapel Hill, NC 27599 USA [3]Huazhong Univ Sci & Technol, Tongji Hosp, Cardiovasc Div Internal Med, Tongji Med Coll, Wuhan 430030, Peoples R China
出处:
ISSN:

摘要:
The adeno-associated viral (AAV) vector has emerged as an attractive vector for gene therapy applications. Development of AAV vectors with enhanced gene transduction efficiency is important to ease the burden of AAV production and minimize potential immune responses. Rational mutations on AAV capsids have gained attention as a simple method of enhancing AAV transduction efficiency. A single-amino acid mutation, K137R, on AAV1 and AAV8 was recently reported to increase liver transgene expression by 5-10-fold. To determine whether the same mutation on other AAV serotypes would result in similar gene enhancement effects, K137R mutants were generated on AAV7, AAV8, and AAV9, and their effects were evaluated in vivo. Two reporter genes were utilized: the nuclear LacZ gene driven by the cytomegalovirus promoter and the luciferase gene driven by the CB promoter. Surprisingly, we found no difference in luciferase gene expression in the liver or other tissues using either the wild-type AAV8 capsid or AAV8-K137R. LacZ gene expression in the liver by AAV8-K137R was about onefold higher than that of wild-type AAV8. However, no difference was found in other tissues, such as skeletal muscle and cardiac muscle. In addition, no difference was found in transgene expression with either AAV7-K137R or AAV9-K137R mutants. Our results indicated that the K137R mutation on AAV7, AAV8, and AAV9 had minimal to no effect on transduction efficiency in vivo.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2013]版:
大类 | 4 区 医学
小类 | 4 区 生物工程与应用微生物 4 区 遗传学 4 区 医学:研究与实验
最新[2025]版:
JCR分区:
出版当年[2012]版:
Q4 GENETICS & HEREDITY Q4 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Q4 MEDICINE, RESEARCH & EXPERIMENTAL
最新[2024]版:

影响因子: 最新[2024版] 最新五年平均 出版当年[2012版] 出版当年五年平均 出版前一年[2011版] 出版后一年[2013版]

第一作者:
第一作者单位: [1]Univ N Carolina, Div Mol Pharmaceut, Eshelman Sch Pharm, Chapel Hill, NC 27599 USA [*1]Univ N Carolina, Div Mol Pharmaceut, Eshelman Sch Pharm, 2072 Genet Med Bldg CB 7362,120 Mason Farm Rd, Chapel Hill, NC 27599 USA
通讯作者:
通讯机构: [1]Univ N Carolina, Div Mol Pharmaceut, Eshelman Sch Pharm, Chapel Hill, NC 27599 USA [*1]Univ N Carolina, Div Mol Pharmaceut, Eshelman Sch Pharm, 2072 Genet Med Bldg CB 7362,120 Mason Farm Rd, Chapel Hill, NC 27599 USA
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:622 今日访问量:0 总访问量:452 更新日期:2025-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)